VAERS reports by lot

GSK Varicella/Shingles lot FA95N: VAERS reports

45 VAERS reports list lot FA95N as a GSK Varicella/Shingles vaccine, received between 2022-07-11 and 2024-05-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
45
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1327%
Neurological817%
Musculoskeletal817%
Dermatological (non-injection-site)817%
Injection-site / Local reaction612%
Cardiac / Cardiovascular24%
Respiratory12%
Gastrointestinal12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 11).

District of Columbia20
California6
Wisconsin3
New York1
New Hampshire1
New Mexico1
Texas1
Florida1
Maine1
North Dakota1
North Carolina1

Reports by month received

2022-071
2022-084
2022-091
2022-105
2022-113
2022-121
2023-032
2023-128
2024-018
2024-028
2024-041
2024-053

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.